Health Professional Radio - Podcast

Dr. Shmuel Shoham, Associate Professor of Medicine at Johns Hopkins University School of Medicine discusses the multi-center, double-blind randomized controlled convalescent blood plasma trials that are currently testing to determine whether giving people antibodies is effective attreating early-stage coronavirus and in preventing those exposed to it from catching the disease. He explains how this research differs from other therapeutics and vaccines under development and why researchers believe it may be promising for COVID-19. He talks about which patients are good candidates for these trials, and what patients can expect if they choose to participate.